Morenas-Rodríguez et al. in their study evaluating the role of CSF progranulin in neurodegenerative diseases, reported no significant association between this biomarker and the performance of patients with different neurodegenerative disorders in MMSE assessment nor cortical atrophy algorithm in these patients [31]. This evidence concerns the gene GRN and Cerebral cortical atrophy.